T1	Participants 391 426	119 women were taken into the study
T2	Participants 444 542	The study group underwent a microdose protocol with a GnRH-agonist followed by rFSH administration
T3	Participants 587 678	119 patients were randomized in three groups to receive daily fixed doses of 300 IU of rFSH
T4	Participants 1144 1232	Clinical pregnancy rates were 13.1%, 15.3%, and 16.1% for group A, group B, and group C,
